Back to search

Could assessment of glioma methylene lipid resonance byin vivo1H-MRS be of clinical value?

Data up to Jan 2025

Published2003
Citations51
References24

Total Citations Per Year

Abstract

References (24)

Glioblastoma multiforme and anaplastic astrocytoma pathologic criteria and prognostic implications

1985 • 659 citations

Accurate, noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy

1996 • 520 citations

Mapping of brain tumor metabolites with proton MR spectroscopic imaging: clinical relevance.

1992 • 357 citations

SVD-based quantification of magnetic resonance signals

1992 • 337 citations

Necrosis as a prognostic criterion in malignant supratentorial, astrocytic gliomas

1983 • 282 citations

Increased choline signal coinciding with malignant degeneration of cerebral gliomas: a serial proton magnetic resonance spectroscopy imaging study

1997 • 273 citations

N‐ACETYL‐<scp>l</scp>‐ASPARTIC ACID CONTENT OF HUMAN NEURAL TUMOURS AND BOVINE PERIPHERAL NERVOUS TISSUES

1972 • 213 citations

Detection of metabolic heterogeneity of human intracranial tumors in vivo by 1h nmr spectroscopic imaging

1990 • 194 citations

The relationship between nuclear magnetic resonance-visible lipids, lipid droplets, and cell proliferation in cultured C6 cells.

1999 • 169 citations

Evidence that mobile lipids detected in rat brain glioma by 1H nuclear magnetic resonance correspond to lipid droplets.

1997 • 142 citations

Correlation of Microvascular Permeability Derived from Dynamic Contrast-Enhanced MR Imaging with Histologic Grade and Tumor Labeling Index

2001 • 112 citations

Diagnostic potential of short echo time MR spectroscopy of gliomas with single-voxel and point-resolved spatially localised proton spectroscopy of brain

2001 • 98 citations

In vivo single‐voxel proton MR spectroscopy in brain lesions with ring‐like enhancement

2001 • 96 citations

Tumor angiogenesis of low-grade astrocytomas measured by dynamic susceptibility contrast-enhanced MRI (DSC-MRI) is predictive of local tumor control after radiation therapy

2001 • 86 citations

Diagnostic assessment of brain tumours and non-neoplastic brain disorders in vivo using proton nuclear magnetic resonance spectroscopy and artificial neural networks

1999 • 83 citations

In Vivo proton MR spectroscopy of human gliomas: definition of metabolic coordinates for multi-dimensional classification

1995 • 71 citations

Lactate turnover in rat glioma measured by in vivo nuclear magnetic resonance spectroscopy.

1998 • 70 citations

Mobile lipid accumulation in necrotic tissue of high grade astrocytomas.

1996 • 62 citations

Determination of proton metabolite concentrations and relaxation parameters in normal human brain and intracranial tumours

1995 • 61 citations

In vivo1H NMR spectroscopy of an intracerebral glioma in the rat

1989 • 43 citations

In vivo measurement of the size of lipid droplets in an intracerebral glioma in the rat

2001 • 40 citations

Good practice in the management of adults with malignant cerebral glioma: clinical guidelines

1997 • 37 citations

Evaluation of metabolic heterogeneity in brain tumors using1H-chemical shift imaging method

1997 • 27 citations

Phospholipid metabolites in 1H-decoupled 31P MRS in vivo in human cancer: implications for experimental models and clinical studies.

1996 • 25 citations

Cited By (0)

Loading...
Could assessment of glioma methylene lipid resonance byin vivo1H-MRS be of clinical value? (2003) – British Journal of Radiology | Metascience Observatory Explorer